Lineage-defined leiomyosarcoma subtypes emerge years before diagnosis and determine patient survivalNathaniel D. Anderson, Adam Shlien, Huayun Hou et al.|Nature Communications|2021Cited by 64
PI3K/AKT/mTOR inhibition in combination with doxorubicin is an effective therapy for leiomyosarcomaYael Babichev, Rebecca A. Gladdy|Journal of Translational Medicine|2016Cited by 53